BridgeBio Pharma nets $135 mln

Palo Alto, California-based BridgeBio Pharma, a clinical-stage biopharmaceutical company, has raised $135 million in funding. Viking Global Investors and KKR led the round with participation from Perceptive Advisors, AIG, Aisling Capital, Cormorant Capital and Janus Funds.

Source: Press Release

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!